These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 472255)

  • 1. Dose tables for 125I seed implants.
    Krishnaswamy V
    Radiology; 1979 Sep; 132(3):727-30. PubMed ID: 472255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose distribution around an 125I seed source in tissue.
    Krishnaswamy V
    Radiology; 1978 Feb; 126(2):489-91. PubMed ID: 622503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose table describing fractions of peripheral volume for 125I volume implants.
    Rosemark PJ; Tobochnik N; Herman MW; Whiting JS; Thompson RW; Weisenburger TH; Metcalf DR; Greenfield MA
    Radiology; 1982 Feb; 142(2):517-20. PubMed ID: 7054846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the dose in permanent implants of I-125].
    Piermattei A; Arcovito G; Andreasi Bassi F; D'Abramo G
    Radiol Med; 1985 Sep; 71(9):626-9. PubMed ID: 4089261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spacing nomograph for interstitial implants of 125I seeds.
    Anderson LL
    Med Phys; 1976; 3(1):48-51. PubMed ID: 1244190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical problems associated with dosimetry of 125-iodine for cancer of the prostate.
    Abadir R; Logan KW
    J Can Assoc Radiol; 1984 Sep; 35(3):250-3. PubMed ID: 6501379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interseed effects on dose for 125I brachytherapy implants.
    Meigooni AS; Meli JA; Nath R
    Med Phys; 1992; 19(2):385-90. PubMed ID: 1584137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations.
    Cormack RA; Holloway CL; O'Farrell D; Devlin PM
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1310-5. PubMed ID: 17967321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.
    Maguire PD; Waterman FM; Dicker AP
    Tech Urol; 2000 Jun; 6(2):85-8. PubMed ID: 10798805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose distribution for 125I implants due to anisotropic radiation emission and unknown seed orientation.
    Prasad SC; Bassano DA; Fear PI
    Med Phys; 1987; 14(2):296-8. PubMed ID: 3587158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
    Sautter-Bihl ML; Wessely R; Bihl H
    Strahlenther Onkol; 1993 Oct; 169(10):595-600. PubMed ID: 8235984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
    D'Souza WD; Thames HD; Kuban DA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose distribution of 125I sources in different tissues.
    Huang DY; Schell MC; Weaver KA; Ling CC
    Med Phys; 1990; 17(5):826-32. PubMed ID: 2233568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation exposure to medical personnel during iodine-125 seed implantation of the prostate.
    Liu J; Edwards FM
    Radiology; 1979 Sep; 132(3):748-9. PubMed ID: 472263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.